Literature DB >> 30173585

Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients.

Hosein Ameri1, Mahmood Yousefi2, Mehdi Yaseri3, Azin Nahvijou4, Mohammad Arab1, Ali Akbari Sari1.   

Abstract

INTRODUCTION: Economic evaluation of healthcare interventions usually needs accurate data on utility and health-related quality-of-life scores. The aim of this study is to map QLQ-C30 scale score onto EQ-5D-5L and SF-6D utility values in colorectal cancer (CRC) patients.
METHODS: EQ-5D-5L, SF-6D, and QLQ-C30 were completed by 252 patients with CRC who were referred to three cancer centers in Tehran between May and September 2017. Moreover, OLS, Tobit, and CLAD models were used to predict EQ-5D-5L and SF-6D values. The goodness of fit of models was evaluated using Pred R2 and Adj R2. In addition, their predictive performance was assessed by MAE, RMSE, ICC, MID, and Spearman's correlation coefficients between observed and predicted EQ-5D-5L and SF-6D values. Models were validated using a 10-fold cross-validation method.
RESULTS: Considering the goodness of fit and predictive ability of models, the OLS Model 2 performed best for EQ-5D-5L (Adj R2 = 58.09%, Pred R2 = 58.93%, MAE = 0.0932, RMSE = 0.129) and the OLS Model 3 performed best for SF-6D (Adj R2 = 54.90%, Pred R2 = 55.62%, MAE = 0.0485, RMSE = 0.0634).
CONCLUSION: Our results demonstrated that algorithms developed based on OLS Models 1 and 2 are the best for predicted EQ-5D-5L and SF-6D values, respectively.

Entities:  

Keywords:  EQ-5D-5L; QLQ-C30; SF-6D; colorectal cancer; quality of life

Mesh:

Year:  2018        PMID: 30173585     DOI: 10.1080/14737167.2018.1517046

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  7 in total

1.  Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in Colorectal Cancer Patients.

Authors:  Hosein Ameri; Mahmood Yousefi; Mehdi Yaseri; Azin Nahvijou; Mohammad Arab; Ali Akbari Sari
Journal:  J Gastrointest Cancer       Date:  2020-03

2.  Health-Related Quality of Life and its Associated Factors in COVID-19 Patients.

Authors:  Morteza Arab-Zozani; Fatemah Hashemi; Hossein Safari; Mahmood Yousefi; Hosein Ameri
Journal:  Osong Public Health Res Perspect       Date:  2020-10

3.  Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.

Authors:  Aurelie Meunier; Alexandra Soare; Helene Chevrou-Severac; Karl-Johan Myren; Tatsunori Murata; Louise Longworth
Journal:  Appl Health Econ Health Policy       Date:  2021-09-23       Impact factor: 3.686

4.  Measurement of Health-Related Quality of Life Among Colorectal Cancer Patients Using the Vietnamese Value Set of the EQ-5D-5L.

Authors:  Binh Thang Tran; Nhu Hiep Pham; Thanh Xuan Nguyen; Kui Son Choi; Dae Kyung Sohn; Sun-Young Kim; Jae Kyung Suh; Thuy Duyen Nguyen; Van Sang Phan; Dinh Trung Tran; The Thanh Nguyen; Thi Thanh Binh Nguyen; Minh Tu Nguyen; Jin-Kyoung Oh
Journal:  Patient Prefer Adherence       Date:  2020-12-04       Impact factor: 2.711

5.  Interim value set for the EQ-5D-5L in Iran using the Crosswalk method.

Authors:  Hosein Ameri; Hossein Safari; Mahmood Yousefi; Saeid Bagheri Faradonbeh; Reza Goudarzi; Moslem Soofi
Journal:  Med J Islam Repub Iran       Date:  2020-09-15

6.  Health-related quality of life and its associated factors in patients with type 2 diabetes mellitus.

Authors:  Forouzan Zare; Hosein Ameri; Farzan Madadizadeh; Mohammad Reza Aghaei
Journal:  SAGE Open Med       Date:  2020-10-26

7.  Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.

Authors:  Yasuhiro Hagiwara; Takeru Shiroiwa; Naruto Taira; Takuya Kawahara; Keiko Konomura; Shinichi Noto; Takashi Fukuda; Kojiro Shimozuma
Journal:  Health Qual Life Outcomes       Date:  2020-11-03       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.